Hy2Care
Hy2Care BV develops a novel technology platform consisting of injectable hydrogels to fight osteoarthritis
Total raised
€14M
€14,200,000
Funding rounds
3
Investors
4
distinct backers
Active since
2019-03
latest 2025-05
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood28
base rate 30% for Other
- ▲ In typical raise window
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood16
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
- ▲ 12y since founding
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-05-16 | Other | €4.5M | Brightlands Venture Partners,European Innovation Council (EIC) Fund,LIOF | View deal → |
| 2022-07-12 | Grant | €6.0M | EIC Accelerator | View deal → |
| 2019-04-01 | Series A | €3.7M | Brightlands Venture Partners | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- Roivant Sciences€1.2BSwitzerland · Healthtech